Nasdaq:US$15.42 (-0.39) | HKEX:HK$25.20 (+0.70) | AIM:£2.36 (+0.1)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 2 Jul 2007

Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis

1 items
a070702